BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26257582)

  • 1. Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues.
    Ren F; Ding H; Huang S; Wang H; Wu M; Luo D; Dang Y; Yang L; Chen G
    Cancer Cell Int; 2015; 15():80. PubMed ID: 26257582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical value of miR-193a-3p in non-small cell lung cancer and its potential molecular mechanism explored
    Gao X; Tang RX; Xie QN; Lin JY; Shi HL; Chen G; Li ZY
    FEBS Open Bio; 2018 Jan; 8(1):94-109. PubMed ID: 29321960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.
    Fan Q; Hu X; Zhang H; Wang S; Zhang H; You C; Zhang CY; Liang H; Chen X; Ba Y
    Cell Physiol Biochem; 2017; 44(4):1311-1324. PubMed ID: 29183007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC: A Clinical Real-Time qRT-PCR Study.
    Liu Y; Ren F; Luo Y; Rong M; Chen G; Dang Y
    Med Sci Monit; 2015 Aug; 21():2352-60. PubMed ID: 26263159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of miR-128-3p, miR-193a-3p and miR-193a-5p in endometrial cancer tissues and their relationship with clinicopathological parameters.
    Wang X; Dai L; Liu J; Ge J
    Cell Mol Biol (Noisy-le-grand); 2022 Aug; 68(8):151-155. PubMed ID: 36800817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
    Liu X; Min S; Wu N; Liu H; Wang T; Li W; Shen Y; Zhao C; Wang H; Qian Z; Xu H; Chen Y; Wang X
    Cancer Lett; 2019 Apr; 447():56-65. PubMed ID: 30685413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
    Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-associated silencing of
    Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53/miR-193a/EGFR feedback loop function as a driving force for non-small cell lung carcinoma tumorigenesis.
    Wang W; Shen XB; Jia W; Huang DB; Wang Y; Pan YY
    Ther Adv Med Oncol; 2019; 11():1758835919850665. PubMed ID: 31205511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of the metastasis-inhibitory mechanism of miR-193a-3p in non-small cell lung cancer.
    Deng W; Yan M; Yu T; Ge H; Lin H; Li J; Liu Y; Geng Q; Zhu M; Liu L; He X; Yao M
    Cell Physiol Biochem; 2015; 35(5):1677-88. PubMed ID: 25833338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer.
    Liao XH; Xie Z; Guan CN
    Neoplasma; 2018 Sep; 65(5):673-682. PubMed ID: 30249107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
    Mamoori A; Wahab R; Islam F; Lee K; Vider J; Lu CT; Gopalan V; Lam AK
    Hum Pathol; 2018 Jan; 71():145-156. PubMed ID: 29104111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA ZFAS1 acts as an oncogene by targeting miR-193a-3p in human non-small cell lung cancer.
    Ge HB; Chen S; Huang SR; Zhu J
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6516-6523. PubMed ID: 31378891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
    Pekow J; Meckel K; Dougherty U; Huang Y; Chen X; Almoghrabi A; Mustafi R; Ayaloglu-Butun F; Deng Z; Haider HI; Hart J; Rubin DT; Kwon JH; Bissonnette M
    Clin Cancer Res; 2017 Sep; 23(17):5281-5291. PubMed ID: 28600480
    [No Abstract]   [Full Text] [Related]  

  • 18. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
    Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y
    Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-384 represses the growth and invasion of non-small-cell lung cancer by targeting astrocyte elevated gene-1/Wnt signaling.
    Fan N; Zhang J; Cheng C; Zhang X; Feng J; Kong R
    Biomed Pharmacother; 2017 Nov; 95():1331-1337. PubMed ID: 28938524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200a-3p and GATA6 are abnormally expressed in patients with non-small cell lung cancer and exhibit high clinical diagnostic efficacy.
    Yu J; He X; Fang C; Wu H; Hu L; Xue Y
    Exp Ther Med; 2022 Apr; 23(4):281. PubMed ID: 35317445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.